St. Jude study highlights a new potential type of vulnerability in solid tumors that may be targeted to enhance immunotherapy efficacy. (IMAGE)

St. Jude Children's Research Hospital

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.